Skip to main content

Advertisement

SpringerLink
Log in

Implications of pars planitis-associated cystoid macular edema on visual outcome and management in children

  • Inflammatory Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

Pars planitis is a commonly observed type of pediatric uveitis. The aim of this study was to evaluate the implications of pars planitis–associated cystoid macular edema (CME) on visual outcome and treatment modalities.

Methods

A retrospective review of medical records in a single center with academic practice.

Results

Included were 33 children (mean age 8 years, 58 eyes). Eighteen eyes developed CME (31%): in 67% of them, CME was diagnosed at presentation and in 33%, it developed at a mean of 57 months after presentation. Anterior and posterior segment complications were more prevalent in eyes with CME. Papillitis was significantly associated with the development of CME (OR 12.4, 95% CI 2.3 to 65.6, p = 0.003). Patients with CME were 1.7 times more likely to be treated with systemic therapy. By the last follow-up, 50% of patients who never developed CME were without systemic therapy compared with 13% of patients who developed CME (p = 0.034). LogMAR visual acuity improvement between presentation and month 36 was 0.41 for eyes with CME compared with 0.14 for eyes that never developed CME (p = 0.009).

Conclusion

Pars planitis–associated CME entailed higher prevalence of ocular complications, more frequent use of immunomodulatory therapy, and a lower rate of remission.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The corresponding author has full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis as well as the decision to submit for publication.

References

  1. Ozdal PC, Berker N, Tugal-Tutkun I (2015) Pars planitis: epidemiology, clinical characteristics, management and visual prognosis. J Ophthalmic Vis Res 10:469–480

    Article  Google Scholar 

  2. Sancho L, Kramer M, Koriat A et al (2019) Complications in intermediate uveitis: prevalence, time of onset, and effects on vision in short-term and long-term follow-up. Ocul Immunol Inflamm 27:447–455

    Article  Google Scholar 

  3. Habot-Wilner Z, Tiosano L, Sanchez JM et al (2018) Demographic and clinical features of pediatric uveitis in Israel. Ocul Immunol Inflamm 17:1–11

    Google Scholar 

  4. de Boer J, Wulffraat N, Rothova A (2003) Visual loss in uveitis of childhood. Br J Ophtalmol 87:879–884

    Article  Google Scholar 

  5. Tugal-Tutkun I (2011) Pediatric uveitis. J Ophthalmic Vis Res 6:259–269

    PubMed  PubMed Central  Google Scholar 

  6. de Boer J, Berendschot TT, van der Does P, Rothova A (2006) Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol 141:616–621

    Article  Google Scholar 

  7. Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516

    Article  Google Scholar 

  8. Nussenblatt RB, Palestine AG, Chan CC, Roberge F (1985) Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92:467–471

    Article  CAS  Google Scholar 

  9. Sicotte NL, Voskuhl RR (2001) Onset of multiple sclerosis associated with anti-TNF therapy. Neurology. 57:1885–1888

    Article  CAS  Google Scholar 

  10. Paroli MP, Spinucci G, Monte R et al (2011) Intermediate uveitis in a pediatric Italian population. Ocul Immunol Inflamm 19:321–326

    Article  Google Scholar 

  11. Jain R, Ferrante P, Reddy GT, Lightman S (2005) Clinical features and visual outcome of intermediate uveitis in children. Clin Exp Ophthalmol 33:22–25

    Article  Google Scholar 

  12. Rosenberg KD, Feuer WJ, Davis JL (2004) Ocular complications of pediatric uveitis. Ophthalmology 111:2299–2306

    Article  Google Scholar 

  13. Khairallah M, Attia S, Zaouali S et al (2006) Pattern of childhood-onset uveitis in a referral center in Tunisia, North Africa. Ocul Immunol Inflamm 14:225–231

    Article  Google Scholar 

  14. Ganesh SK, Bala A, Biswas J, Ahmed AS, Kempen JH (2016) Pattern of pediatric uveitis seen at a tertiary referral center from India. Ocul Immunol Inflamm 24(4):402–409

    PubMed  Google Scholar 

  15. Keino H, Watanabe T, Taki W et al (2017) Clinical features of uveitis in children and adolescents at a tertiary referral centre in Tokyo. Br J Ophthalmol 101:406–410

    Article  Google Scholar 

  16. Päivönsalo-Hietanen T, Tuominen J, Saari KM (2000) Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand 78(1):84–88

    Article  Google Scholar 

  17. Azar D, Martin F (2004) Paediatric uveitis: a Sydney clinic experience. Clin Exp Ophthalmol 32(5):468–471

    Article  Google Scholar 

  18. Kump LI, Cervantes-Castañeda RA, Androudi SN, Foster CS (2005) Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology 112:1287–1292

    Article  Google Scholar 

  19. Kalinina Ayuso V, ten Cate HA, van den Does P et al (2011) Young age as a risk factor for complicated course and visual outcome in intermediate uveitis in children. Br J Ophthalmol 95:646–651

    Article  CAS  Google Scholar 

  20. Le Scanff J, Sève P, Renoux C et al (2008) Uveitis associated with multiple sclerosis. Mult Scler 14:415–417

    Article  Google Scholar 

  21. Smith JR, Rosenbaum JT (2004) Neurological concomitants of uveitis. Br J Ophthalmol 88:1498–1499

    Article  CAS  Google Scholar 

  22. Zein G, Berta A, Foster CS (2004) Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 12:137–142

    Article  Google Scholar 

  23. van Oosten B, Barkhof F, Truyen L et al (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47:1531–1534

    Article  Google Scholar 

  24. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) TNF neutralization in MS: results of a randomized, placebo controlled multicenter study. Neurology 53:457–465

    Article  Google Scholar 

  25. Probert L (2015) TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects. Neuroscience 302:2–22

    Article  CAS  Google Scholar 

  26. Ding T, Ledingham J, Luqmani R et al (2010) BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. Rheumatology 49:2217–2219

    Article  Google Scholar 

  27. Kemanetzoglou E, Andreadou E (2017) CNS demyelination with TNF-α blockers. Curr Neurol Neurosci Rep 17:36

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Hadassah Medical Center, POB 12000, 91120, Jerusalem, Israel

    Ana Navarrete, Adi Koriat & Radgonde Amer

Authors
  1. Ana Navarrete
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adi Koriat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Radgonde Amer
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed by collecting information and analyzing, writing, and reviewing the manuscript.

Corresponding author

Correspondence to Radgonde Amer.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

This type of study does not require informed consent.

Code availability

Not relevant

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Navarrete, A., Koriat, A. & Amer, R. Implications of pars planitis-associated cystoid macular edema on visual outcome and management in children. Graefes Arch Clin Exp Ophthalmol 258, 1803–1811 (2020). https://doi.org/10.1007/s00417-020-04696-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-020-04696-7

Keywords

Search

Navigation